RN Laura Miller was driving home from her shift at Hartford Hospital when she came upon the accident scene, in today's bite-sized hospital and health industry news from Connecticut, Indiana, and Georgia.
Teva Pharmaceutical Industries on Tuesday released a generic version of Mylan's EpiPen for children who weigh between 33 and 66 pounds, which will be available in the majority of retail pharmacies for $300 for a two-pack.
NIH on Wednesday announced that it will give the 25,000 participants of its All of Us precision medicine project their genetic testing results, marking the first time a government study has shared individualized genetic data with participants.
It's long been medical advice for patients to avoid food and drink before they receive anesthesia, but with the rising popularity of cannabis, doctors have a new pre-surgical precaution: Avoid marijuana beforehand—and tell your doctor if you use it, Naomi Martin reports for the Boston Globe.
More than one-third of clinical trials that led to the approval of new cancer drugs between 2008 and 2018 did not include data on participants' race, according to a new study published in JAMA Oncology.
HHS' Substance Abuse and Mental Health Services Administration on Thursday released a proposed rule intended to make it easier for providers to share the medical records of patients being treated for substance use disorders.
Writing for the New York Times, Kim Tingley explores how step-counting became such an exercise fad, whether it's truly an effective way to measure physical activity—and how many daily steps you really need to take to gain health benefits.